Opportunity Information: Apply for RFA CA 23 026
The National Institutes of Health (NIH) funding opportunity "Advancing Cancer Control Equity Research Through Transformative Solutions" (RFA-CA-23-026) supports research programs aimed at reducing cancer inequities by focusing on how social determinants of health (SDOH) drive worse cancer outcomes in underserved communities. This opportunity uses a U19 cooperative agreement mechanism, meaning funded projects are expected to involve substantial NIH scientific and programmatic involvement in addition to the awardee-led work. The activity area is health, and clinical trials are optional under this announcement.
At its core, the program is designed to stimulate community-engaged, multilevel intervention research in cancer control. "Multilevel" here means applicants are expected to go beyond single-point solutions and instead address interconnected pathways that operate across levels such as individuals, families, health care systems, neighborhoods, and broader policy or structural environments. The goal is not only to test or implement interventions, but to do so in ways that directly respond to real-world conditions that shape cancer prevention, screening, diagnosis, treatment, survivorship, and mortality patterns.
The announcement lays out three main expectations for applicants. First, projects should develop interventions that explicitly target the pathways through which SDOH contribute to adverse cancer outcomes. This implies interventions should be theory-driven and designed to interrupt or change the mechanisms linking social and structural conditions (for example, access barriers, discrimination, transportation, housing instability, food insecurity, insurance gaps, or neighborhood-level resource deficits) to cancer-related disparities. Second, applicants are expected to develop or strengthen methods and measures to assess community-level SDOH as well as community engagement processes and cancer control equity outcomes. In practice, this emphasis signals that NIH is looking for strong measurement strategies, meaningful indicators of equity-related change, and rigorous approaches for evaluating both how community engagement is carried out and whether it improves intervention relevance, uptake, and impact. Third, the program aims to build capacity among diverse scholars, stakeholders, and community partners to implement interventions grounded in lived experience. That capacity-building focus suggests that competitive applications will demonstrate authentic partnership structures, shared decision-making, training or mentorship components, and plans to sustain equitable collaboration beyond the life of the grant.
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations (both 501(c)(3) and non-501(c)(3), excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The opportunity also explicitly highlights additional eligible applicant groups such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), as well as faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, foreign organizations and foreign institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Key administrative details included in the source information are that the award instrument is a cooperative agreement, the Assistance Listing (CFDA) number is 93.396, and the original closing date was September 14, 2023. The listed award ceiling is $1,500,000, indicating the maximum funding level per award under the terms described in the posting. Overall, the opportunity is positioned for teams capable of combining rigorous cancer control research with deep community partnership, strong multilevel intervention design, and practical measurement approaches that can demonstrate progress toward equity in real settings.Apply for RFA CA 23 026
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396.
- This funding opportunity was created on 2023-06-28.
- Applicants must submit their applications by 2023-09-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: DoD Research and Education Program for Historically Black Colleges and Universities and Minority-Serving Institutions (HBCU/MI) Research Fiscal Year 2024
Previous opportunity: Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 23 026
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 23 026) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AT 24 002 Funding Number: RFA AT 24 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,300,000 |
| ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed) Apply for RFA OD 23 018 Funding Number: RFA OD 23 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Apply for PA 23 231 Funding Number: PA 23 231 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 037 Funding Number: RFA CA 23 037 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 036 Funding Number: RFA CA 23 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: $325,000 |
| NIH-DoD-VA Pain Management Collaboratory ? Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 24 004 Funding Number: RFA AT 24 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 25 014 Funding Number: RFA DA 25 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 23 246 Funding Number: PAR 23 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) Apply for RFA DA 25 020 Funding Number: RFA DA 25 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) Apply for RFA DA 25 019 Funding Number: RFA DA 25 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required) Apply for RFA DA 25 002 Funding Number: RFA DA 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional) Apply for RFA DA 25 001 Funding Number: RFA DA 25 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 23 254 Funding Number: PAR 23 254 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 23 255 Funding Number: PAR 23 255 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 23 245 Funding Number: PAR 23 245 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Apply for PAR 23 259 Funding Number: PAR 23 259 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 23 243 Funding Number: PAR 23 243 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 23 242 Funding Number: PAR 23 242 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Apply for PAR 23 264 Funding Number: PAR 23 264 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 273 Funding Number: PAR 23 273 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 026", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.